These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27986882)

  • 1. General Biomarker Recommendations for Lymphoma.
    Rimsza L; Fedoriw Y; Staudt LM; Melnick A; Gascoyne R; Crump M; Baizer L; Fu K; Hsi E; Chan JW; McShane L; Leonard JP; Kahl BS; Little RF; Friedberg JW; Kostakoglu L
    J Natl Cancer Inst; 2016 Dec; 108(12):. PubMed ID: 27986882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.
    Abrams J; Conley B; Mooney M; Zwiebel J; Chen A; Welch JJ; Takebe N; Malik S; McShane L; Korn E; Williams M; Staudt L; Doroshow J
    Am Soc Clin Oncol Educ Book; 2014; ():71-6. PubMed ID: 24857062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 30 years of lymph node pathology: biomarkers and other advances.
    Ramsay AD
    Appl Immunohistochem Mol Morphol; 2013 Mar; 21(2):103-9. PubMed ID: 23417072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations for Clinical Trial Development in Follicular Lymphoma.
    Maddocks K; Barr PM; Cheson BD; Little RF; Baizer L; Kahl BS; Leonard JP; Fowler N; Gordon LI; Link BK; Friedberg JW; Ansell SM
    J Natl Cancer Inst; 2017 Mar; 109(3):. PubMed ID: 28040699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hodgkin Lymphoma: Current Status and Clinical Trial Recommendations.
    Diefenbach CS; Connors JM; Friedberg JW; Leonard JP; Kahl BS; Little RF; Baizer L; Evens AM; Hoppe RT; Kelly KM; Persky DO; Younes A; Kostakaglu L; Bartlett NL
    J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 28040700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Search of Platinum Meter Bar for Measurement of Metabolic Tumor Volume in Lymphoma.
    Gallamini A
    J Nucl Med; 2019 Aug; 60(8):1094-1095. PubMed ID: 31171597
    [No Abstract]   [Full Text] [Related]  

  • 7. Image-guided needle biopsy for diagnosis and molecular biology in lymphomas.
    de Kerviler E; Benet C; Brière J; de Bazelaire C
    Best Pract Res Clin Haematol; 2012 Mar; 25(1):29-39. PubMed ID: 22409821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Informatics Approaches to Address New Challenges in the Classification of Lymphoid Malignancies.
    Jordan J; Goldstein JS; Jaye DL; Gurcan M; Flowers CR; Cooper LAD
    JCO Clin Cancer Inform; 2018; 2():. PubMed ID: 30637363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET/CT for Staging; Past, Present, and Future.
    El-Galaly TC; Gormsen LC; Hutchings M
    Semin Nucl Med; 2018 Jan; 48(1):4-16. PubMed ID: 29195617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin receptor expression in lymphomas: a source of false diagnosis of neuroendocrine tumor at
    Ruuska T; Ramírez Escalante Y; Vaittinen S; Gardberg M; Kiviniemi A; Marjamäki P; Kemppainen J; Jyrkkiö S; Minn H
    Acta Oncol; 2018 Feb; 57(2):283-289. PubMed ID: 28686510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial staging of lymphoma with octreotide and other receptor imaging agents.
    Ferone D; Semino C; Boschetti M; Cascini GL; Minuto F; Lastoria S
    Semin Nucl Med; 2005 Jul; 35(3):176-85. PubMed ID: 16098291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial staging of lymphoma with positron emission tomography and computed tomography.
    Hicks RJ; Mac Manus MP; Seymour JF
    Semin Nucl Med; 2005 Jul; 35(3):165-75. PubMed ID: 16098290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-Cell Lymphoma: Recent Advances in Characterization and New Opportunities for Treatment.
    Casulo C; O'Connor O; Shustov A; Fanale M; Friedberg JW; Leonard JP; Kahl BS; Little RF; Pinter-Brown L; Advani R; Horwitz S
    J Natl Cancer Inst; 2017 Feb; 109(2):. PubMed ID: 28040682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staging and response assessment in lymphomas: the new Lugano classification.
    Cheson BD
    Chin Clin Oncol; 2015 Mar; 4(1):5. PubMed ID: 25841712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New trends and novel possibilities in the diagnosis of lymphomas].
    Illés Á; Simon Z
    Magy Onkol; 2015 Mar; 59(1):73-8. PubMed ID: 25763917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas.
    Specht L
    Semin Radiat Oncol; 2007 Jul; 17(3):190-7. PubMed ID: 17591566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indolent Lymphomas That Present With Clinically Aggressive Features: A Subset of Low-Grade Lymphomas With a Behavior Inconsistent With the Histologic Diagnosis.
    Cabanillas F; Rivera N; Pardo WI
    Clin Lymphoma Myeloma Leuk; 2016 Oct; 16(10):550-557. PubMed ID: 27618361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations for collection and handling of specimens from group breast cancer clinical trials.
    Leyland-Jones BR; Ambrosone CB; Bartlett J; Ellis MJ; Enos RA; Raji A; Pins MR; Zujewski JA; Hewitt SM; Forbes JF; Abramovitz M; Braga S; Cardoso F; Harbeck N; Denkert C; Jewell SD; ; ; ; ; ; ; ; ; ; ; ;
    J Clin Oncol; 2008 Dec; 26(34):5638-44. PubMed ID: 18955459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents.
    Inamdar AA; Goy A; Ayoub NM; Attia C; Oton L; Taruvai V; Costales M; Lin YT; Pecora A; Suh KS
    Oncotarget; 2016 Jul; 7(30):48692-48731. PubMed ID: 27119356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.